Zavabresib
Zavabresib is an investigational new drug that is being evaluated by Plexxikon/Opna Bio for the treatment of myelofibrosis.
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Zavabresib is an investigational new drug that is being evaluated by Plexxikon/Opna Bio for the treatment of myelofibrosis. It is a BRD4 protein inhibitor.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1375002423 under CC BY-SA 4.0; modifications have been made.